No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
ATAI Life Sciences Finalizes Separation With CBO
Reported Earlier: 'Texas Lawmakers Take Up Bills To Expedite Access To Psychedelic Therapy' - Marijuana Moment
Atai Life Sciences Started at Positive by Berenberg
World's First AI Stem Cell-engineered Cognitive AI Platform Launched by Irish-based Partsol
Atai Life Sciences CEO Discusses Major Data Readouts Expected Through 2025 - ICYMI | NASDAQ:ATAI, ETR:9VC
Atai Life Sciences Director Angermayer Buys $2.52 Million in Shares